Browse Indicators

Operations
 Indicator title
(GEND_GBV) Number of people receiving post-gender-based violence (GBV) clinical care based on the minimum package
(KP_MAT) Number of people who inject drugs (PWID) on medication-assisted therapy (MAT) for at least 6 months
(KP_PREV) Number of key populations reached with individual and/or small group-level HIV prevention interventions designed for the target population
(OVC_SERV) Number of beneficiaries served by PEPFAR OVC programs for children and families affected by HIV
Condom use among sex workers
Condom use among gay and other men who have sex with men
(PP_PREV) Number of priority populations (PP) reached with the standardized, evidence-based intervention(s) required that are designed to promote the adoption of HIV prevention behaviors and service uptake
(PrEP_CURR) Number of individuals, inclusive of those newly enrolled, that received oral antiretroviral pre- exposure prophylaxis (PrEP) to prevent HIV during the reporting period
(PrEP_NEW) Number of individuals who were newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV infection in the reporting period
(TB_PREV) Proportion of ART patients who started on a standard course of TB Preventive Treatment (TPT) in the previous reporting period who completed therapy
Young people: knowledge about HIV prevention
(VMMC_CIRC) Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period
(CXCA_SCRN) (including CXCA_SCRN_POS) Percentage of HIV-positive women on ART screened for cervical cancer
(HTS_Index) Number of individuals who were identified and tested using Index testing services and received their results
(HTS_RECENT) Number of newly diagnosed HIV-positive persons who received testing for recent infection with a documented result during the reporting period
(HTS_SELF) Number of individual HIV self-test kits distributed
(HTS_TST) (including HTS_TST_POS) Number of individuals who received HIV Testing Services (HTS) and received their test results
(OVC_HIVSTAT) Percentage of orphans and vulnerable children (<18 years old) with HIV status reported to implementing partner
(PMTCT_EID) Percentage of infants born to HIV-positive women who received a first virologic HIV test (sample collected) by 12 months of age
(PMTCT_FO) Percentage of final outcomes among HIV exposed infants registered in a birth cohort
(PMTCT_HEI_POS) Number of HIV-infected infants identified in the reporting period, whose diagnostic sample was collected by 12 months of age
(PMTCT_STAT) (including PMTCT_STAT_POS) Percentage of pregnant women with known HIV status at antenatal care (includes those who already knew their HIV status prior to ANC)
(TB_STAT) (including TB_STAT_POS) Percentage of new and relapse TB cases with documented HIV status
(CXCA_TX) Percentage of cervical cancer screen-positive women who are HIV-positive and on ART eligible for cryotherapy, thermocoagulation or LEEP who received cryotherapy, thermocoagulation or LEEP
(PMTCT_ART) Percentage of HIV-positive pregnant women who received ART to reduce the risk of mother-to-child-transmission (MTCT) during pregnancy

Pages